Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Galactose-1-phosphate uridyl transferase (GALT) catalyzes the second step of the Leloir pathway of galactose metabolism, namely the conversion of UDP-glucose + galactose-1-phosphate to glucose-1-phosphate + UDP-galactose. Additionally we are shipping Galactose-1-Phosphate Uridylyltransferase Antibodies (83) and Galactose-1-Phosphate Uridylyltransferase Proteins (21) and many more products for this protein.
Showing 4 out of 14 products:
GALT mutation is associated with galactosemia.
The mutational spectrum of the GALT gene in Greek galactosemia patients is presented for the first time.
novel splicing mutation in GALT gene causing Galactosemia in Ecuadorian family
17 VUS (37%; 7 in ACADM, 9 in GALT, and 1 in PAH) were reclassified from uncertain (6 to benign or likely benign and 11 to pathogenic or likely pathogenic). We identified common types of missing information that would have helped make a definitive classification and categorized this information by ease and cost to obtain
we present the 1.9 A resolution crystal structure of human GALT (hGALT) ternary complex, revealing a homodimer arrangement that contains a covalent uridylylated intermediate and glucose-1-phosphate in the active site, as well as a structural zinc-binding site, per monomer
A novel noncoding homozygous GALT variant associated with asymptomatic galactosemia has been described in an infant of consanguineous heterozygous parents.
Mutation activates a cryptic donor splice site, inducing an aberrant splicing of the GALT pre-mRNA, which in turn leads to a frameshift with inclusion of a premature stop codon.
GALT activity in red blood cells of patients with galactosaemia
In Korean population, novel GALT mutations were identified in the galactosemia patients different from those of other populations.
suggests that GALT mutations are ethnic-specific and that galactosemia is a heterogeneous disorder at the molecular level
Our results thus demonstrated that GalT deficiency can effect down-regulation of the PI3K/Akt (show AKT1 ELISA Kits) growth signaling pathway in mouse fibroblasts through distinct mechanisms targeting both gene and protein expression levels.
Administration of a high-galactose (40% w/w) diet to lactating homozygous GalT gene-trapped females led to lethality in over 70% of the homozygous GalT gene-trapped pups before weaning.
Effects of GALT deficiency and dietary galactose on UDP-glucose pyrophosphorylase and UDP-galactose (show B3GALT1 ELISA Kits) pyrophosphorylase activity and uridine diphosphate glucose expression in liver of mice with homozygous deletion of the critical regions of galt.
The finding is consistent with the function of UDP galactose pyrophosphorylase as an alternate pathway of galactose metabolism.
Data show that PRL (show PRL ELISA Kits) signals through the short form of PRL (show PRL ELISA Kits) receptor RL, and causes, iin the absence of RL, a severe ovarian pathology by repressing the expression of FOXO3 (show FOXO3 ELISA Kits) and that of its target gene Galt.
Galactose-1-phosphate uridyl transferase (GALT) catalyzes the second step of the Leloir pathway of galactose metabolism, namely the conversion of UDP-glucose + galactose-1-phosphate to glucose-1-phosphate + UDP-galactose. The absence of this enzyme results in classic galactosemia in humans and can be fatal in the newborn period if lactose is not removed from the diet. The pathophysiology of galactosemia has not been clearly defined. Two transcript variants encoding different isoforms have been found for this gene.
, gal-1-P uridylyltransferase
, galactose-1-phosphate uridyl transferase
, galactose-1-phosphate uridylyltransferase
, galactose-1-phosphate uridylyltransferase, GalT
, galactose-1-phosphate uridylyltransferase GALT
, GalT galactose-1-phosphate uridylyltransferase
, Galactose-1-phosphate uridylyltransferase
, galactose-1P uridylyltransferase